Cumberland Pharmaceuticals Inc Stock Ownership - Who owns Cumberland Pharmaceuticals?

Insider buying vs selling

Have Cumberland Pharmaceuticals Inc insiders been buying or selling?
James JonesDirector2023-03-241,000$1.97
Joseph C. GalanteDirector2023-03-241,000$1.92
Kenneth KrogulskiDirector2023-03-245,000$1.97
Martin S. Brown Jr.Director2023-03-241,000$1.97
Caroline YoungDirector2023-03-241,000$1.97
James L. HermanVP and Chief Compliance Office2023-03-181,280$1.92
A. J. KazimiChairman and CEO2023-03-1837,205$1.92
Joey A. JacobsDirector2023-01-145,000$2.75
Kenneth KrogulskiDirector2022-12-21360$2.22
Joseph C. GalanteDirector2022-12-21180$2.22

1 of 70

CPIX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CPIX insiders and whales buy or sell their stock.

CPIX Shareholders

What type of owners hold Cumberland Pharmaceuticals Inc stock?
A. J. Kazimi39.71%5,716,153$11.15MInsider
Dimensional Fund Advisors LP4.33%623,871$1.22MInstitution
Lawrence W. Greer4.05%583,344$1.14MInsider
Renaissance Technologies LLC4.04%581,963$1.13MInstitution
Jean W. Marstiller3.06%440,828$859.61kInsider
Robert Edwards2.90%417,569$814.26kInsider
Vanguard Group Inc2.60%374,826$730.91kInstitution
Bridgeway Capital Management LLC1.99%286,655$558.98kInstitution
Kenneth Krogulski1.46%209,955$409.41kInsider
Thomas R. Lawrence1.42%204,110$398.01kInsider

1 of 3

CPIX vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CPIX17.32%57.41%Net SellingNet Selling
DERM14.98%16.19%Net SellingNet Selling
NLTX39.76%41.65%Net SellingNet Selling
MDVL35.80%64.20%Net BuyingNet Selling

Cumberland Pharmaceuticals Stock Ownership FAQ

Who owns Cumberland Pharmaceuticals?

Cumberland Pharmaceuticals (NASDAQ: CPIX) is owned by 17.32% institutional shareholders, 57.41% Cumberland Pharmaceuticals insiders, and 25.27% retail investors. A. J. Kazimi is the largest individual Cumberland Pharmaceuticals shareholder, owning 5.72M shares representing 39.71% of the company. A. J. Kazimi's Cumberland Pharmaceuticals shares are currently valued at $11.15M.

If you're new to stock investing, here's how to buy Cumberland Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.